Company Profiles: Janssen Inc
Author :
Publisher :
Page : pages
File Size : 33,73 MB
Release :
Category :
ISBN :
Company Profiles: Janssen Pharmaceuticals Inc
Author :
Publisher :
Page : pages
File Size : 47,4 MB
Release :
Category :
ISBN :
Book Description
Company Profiles: Janssen Biotech, Inc
Author :
Publisher :
Page : pages
File Size : 43,58 MB
Release :
Category :
ISBN :
Book Description
Company Profiles: Xian-Janssen Pharmaceutical Ltd
Author :
Publisher :
Page : pages
File Size : 16,99 MB
Release :
Category :
ISBN :
Book Description
Company Profiles: Janssen Pharmaceutical KK.
Author :
Publisher :
Page : pages
File Size : 37,22 MB
Release :
Category :
ISBN :
Book Description
Company Profiles: Janssen Pharmaceutica NV.
Author :
Publisher :
Page : pages
File Size : 12,75 MB
Release :
Category :
ISBN :
Book Description
EPA's 33/50 Program Company Profile
Author :
Publisher :
Page : 156 pages
File Size : 40,84 MB
Release : 1994
Category : Aerospace industries
ISBN :
Book Description
NAMZARIC Drug Profile, 2023
Author : DrugPatentWatch
Publisher : DrugPatentWatch.com
Page : 114 pages
File Size : 33,19 MB
Release : 2023-08-15
Category : Medical
ISBN : 1934899704
Book Description
NAMZARIC Drug Profile, 2023
This report focuses on NAMZARIC and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- Patent Trial and Appeal Board (PTAB) patent cases
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
NUCYNTA ER Drug Profile, 2023
Author : DrugPatentWatch
Publisher : DrugPatentWatch.com
Page : 153 pages
File Size : 27,67 MB
Release : 2023-08-15
Category : Medical
ISBN : 1934899631
Book Description
NUCYNTA ER Drug Profile, 2023
This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- Patent Trial and Appeal Board (PTAB) patent cases
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
Company Profiles: S.C. Johnson & Son, Inc
Author :
Publisher :
Page : pages
File Size : 46,33 MB
Release :
Category :
ISBN :
